1. P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS. (23rd June 2022) Authors: Khwaja, J.; Bomsztyk, J.; Mahmood, S.; Wisniowski, B.; Shah, R.; Tailor, A.; Yong, K.; Popat, R.; Rabin, N.; Kyriakou, C.; Sive, J.; Worthington, S.; Hart, A.; Dowling, E.; Correia, N.; Bygrave, C.; Rydzewski, A.; Jamroziak, K.; Wechalekar, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-05 Retrospective cohort observational study of venous and arterial thrombotic event rates in POEMS patients: results from the UK-based POEMS registry and mechanistic insights. Issue 200 (April 2021) Authors: Sayar, Z.; Weatherill, A.; Keddie, S.; Sive, J.; Lunn, M.P.; Thomas, M.; D'Sa, S. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗